Neurocrine Biosciences Inc
XMUN:NB3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Neurocrine Biosciences Inc
XMUN:NB3
|
US |
|
Q
|
Quadient SA
OTC:NPACF
|
FR |
|
Mizuho Financial Group Inc
OTC:MZHOF
|
JP |
Multiples-Based Value
The Multiples-Based Value for
Neurocrine Biosciences Inc (NB3) under the Base Case is 129.42 EUR.
Compared with the current market price of 136.88 EUR, the stock appears
Overvalued by 5% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.